pacs group inc - PACS
PACS
Close Chg Chg %
48.77 0.35 0.72%
Closed Market
49.12
+0.35 (0.72%)
Volume: 700.99K
Last Updated:
Nov 10, 2026, 3:59 PM EDT
Company Overview: pacs group inc - PACS
PACS Key Data
| Open $48.80 | Day Range 48.26 - 49.26 |
| 52 Week Range 10.31 - 51.68 | Market Cap $7.87B |
| Shares Outstanding 158.72M | Public Float 45.62M |
| Beta -0.14 | Rev. Per Employee N/A |
| P/E Ratio 28.81 | EPS $1.76 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 913.77K |
PACS Performance
| 1 Week | -1.67% | ||
| 1 Month | 12.63% | ||
| 3 Months | 9.74% | ||
| 1 Year | 360.96% | ||
| 5 Years | N/A |
PACS Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
6
Full Ratings ➔
About pacs group inc - PACS
PACS Group, Inc. is a holding company, which engages in the provision of post-acute healthcare facilities, professionals, and ancillary services. It provides senior care, assisted living, and independent living options in some of the communities. The company was founded by Jason Murray and Mark Hancock in 2013 and is headquartered in Salt Lake City, UT.
PACS At a Glance
PACS Group, Inc.
90 South 400 West
Salt Lake City, Utah 84101
| Phone | 1-801-447-9829 | Revenue | 5.29B | |
| Industry | Hospital/Nursing Management | Net Income | 191.54M | |
| Sector | Health Services | 2025 Sales Growth | 29.322% | |
| Fiscal Year-end | 12 / 2026 | Employees | 47,455 | |
| View SEC Filings |
PACS Valuation
| P/E Current | 28.81 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 31.405 |
| Price to Sales Ratio | 1.137 |
| Price to Book Ratio | 6.35 |
| Price to Cash Flow Ratio | 14.88 |
| Enterprise Value to EBITDA | 25.679 |
| Enterprise Value to Sales | 1.775 |
| Total Debt to Enterprise Value | 0.383 |
PACS Efficiency
| Revenue/Employee | 111,451.522 |
| Income Per Employee | 4,036.308 |
| Receivables Turnover | 7.533 |
| Total Asset Turnover | 0.841 |
PACS Liquidity
| Current Ratio | 1.068 |
| Quick Ratio | 1.068 |
| Cash Ratio | 0.232 |
PACS Profitability
| Gross Margin | 13.702 |
| Operating Margin | 5.86 |
| Pretax Margin | 5.378 |
| Net Margin | 3.622 |
| Return on Assets | 3.045 |
| Return on Equity | 23.129 |
| Return on Total Capital | 4.215 |
| Return on Invested Capital | 4.571 |
PACS Capital Structure
| Total Debt to Total Equity | 380.037 |
| Total Debt to Total Capital | 79.168 |
| Total Debt to Total Assets | 55.714 |
| Long-Term Debt to Equity | 360.342 |
| Long-Term Debt to Total Capital | 75.066 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Pacs Group Inc - PACS
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 2.42B | 3.11B | 4.09B | 5.29B | |
Sales Growth
| +107.62% | +28.47% | +31.44% | +29.32% | |
Cost of Goods Sold (COGS) incl D&A
| 2.04B | 2.69B | 3.62B | 4.56B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 22.31M | 25.63M | 40.81M | 55.66M | |
Depreciation
| - | - | - | - | - |
Amortization of Intangibles
| - | - | - | - | - |
COGS Growth
| +107.19% | +31.63% | +34.68% | +25.99% | |
Gross Income
| 378.37M | 421.44M | 466.88M | 724.66M | |
Gross Income Growth
| +109.98% | +11.38% | +10.78% | +55.21% | |
Gross Profit Margin
| +15.62% | +13.54% | +11.42% | +13.70% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 149.01M | 169.94M | 341.30M | 414.76M | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 149.01M | 169.94M | 341.30M | 414.76M | |
SGA Growth
| +53.88% | +14.05% | +100.84% | +21.52% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | 43.73M | (4.39M) | 310.00K | |
EBIT after Unusual Expense
| 229.36M | 207.77M | 129.97M | 309.60M | |
Non Operating Income/Expense
| 3.22M | (536.00K) | 15.93M | 3.22M | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | (346.00K) | (391.00K) | (2.74M) | |
Interest Expense
| 25.54M | 49.92M | 44.34M | 28.36M | |
Interest Expense Growth
| +383.86% | +95.47% | -11.17% | -36.03% | |
Gross Interest Expense
| 25.54M | 49.92M | 44.34M | 28.36M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 207.04M | 157.32M | 101.55M | 284.45M | |
Pretax Income Growth
| +154.27% | -24.02% | -35.45% | +180.10% | |
Pretax Margin
| +8.55% | +5.06% | +2.48% | +5.38% | |
Income Tax
| 56.55M | 44.44M | 46.21M | 92.99M | |
Income Tax - Current - Domestic
| 52.98M | 54.36M | 97.02M | 110.72M | |
Income Tax - Current - Foreign
| - | - | - | - | - |
Income Tax - Deferred - Domestic
| 3.57M | (9.92M) | (50.81M) | (17.73M) | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | (346.00K) | (391.00K) | (2.74M) | |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 150.50M | 112.88M | 55.34M | 191.46M | |
Minority Interest Expense
| - | 8.00K | (416.00K) | (82.00K) | |
Net Income
| 150.50M | 112.87M | 55.76M | 191.54M | |
Net Income Growth
| +213.88% | -25.00% | -50.60% | +243.51% | |
Net Margin Growth
| +6.21% | +3.63% | +1.36% | +3.62% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 150.50M | 112.87M | 55.76M | 191.54M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 150.50M | 112.87M | 55.76M | 191.54M | |
EPS (Basic)
| 6.1071 | 4.5804 | 0.3593 | 1.2264 | |
EPS (Basic) Growth
| +213.88% | -25.00% | -92.16% | +241.33% | |
Basic Shares Outstanding
| 24.64M | 24.64M | 155.18M | 156.18M | |
EPS (Diluted)
| 6.1071 | 4.5804 | 0.3593 | 1.2224 | |
EPS (Diluted) Growth
| +213.88% | -25.00% | -92.16% | +240.22% | |
Diluted Shares Outstanding
| 24.64M | 24.64M | 155.18M | 156.70M | |
EBITDA
| 251.67M | 277.13M | 166.39M | 365.57M | |
EBITDA Growth
| +178.05% | +10.12% | -39.96% | +119.71% | |
EBITDA Margin
| +10.39% | +8.91% | +4.07% | +6.91% |
Snapshot
| Average Recommendation | BUY | Average Target Price | 59.00 | |
| Number of Ratings | 6 | Current Quarters Estimate | 0.626 | |
| FY Report Date | 12 / 2026 | Current Year's Estimate | 2.429 | |
| Last Quarter’s Earnings | 0.63 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.844 | Next Fiscal Year Estimate | 2.743 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 6 | 3 | 6 | 6 |
| Mean Estimate | 0.63 | 0.66 | 2.43 | 2.74 |
| High Estimates | 0.73 | 0.70 | 2.84 | 3.10 |
| Low Estimate | 0.57 | 0.62 | 2.02 | 2.52 |
| Coefficient of Variance | 8.90 | 6.06 | 12.56 | 7.91 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 6 | 6 | 6 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 0 | 0 | 0 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for Pacs Group Inc - PACS
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Pacs Group Inc - PACS
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Nov 5, 2026 | Jason Murray Co-Founder, CEO & Chairman; Director | 54,150,285 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $45.94 per share | 2,487,664,092.90 |
| Nov 5, 2026 | Jason Murray Co-Founder, CEO & Chairman; Director | 54,148,418 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $46.87 per share | 2,537,936,351.66 |
| Nov 5, 2026 | Jason Murray Co-Founder, CEO & Chairman; Director | 54,148,039 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $47.78 per share | 2,587,193,303.42 |
| Nov 5, 2026 | Jason Murray Co-Founder, CEO & Chairman; Director | 54,142,959 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $46.19 per share | 2,500,863,276.21 |
| Nov 5, 2026 | Jason Murray Co-Founder, CEO & Chairman; Director | 54,121,535 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $46.57 per share | 2,520,439,884.95 |
| Nov 5, 2026 | Jason Murray Co-Founder, CEO & Chairman; Director | 54,117,535 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $47.48 per share | 2,569,500,561.80 |
| Nov 5, 2026 | Jason Murray Co-Founder, CEO & Chairman; Director | 54,111,338 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.56 per share | 2,627,646,573.28 |
| Nov 5, 2026 | Jason Murray Co-Founder, CEO & Chairman; Director | 54,099,005 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $49.6 per share | 2,683,310,648.00 |
| Nov 5, 2026 | Jason Murray Co-Founder, CEO & Chairman; Director | 53,965,691 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $50.37 per share | 2,718,251,855.67 |
| Nov 5, 2026 | Jason Murray Co-Founder, CEO & Chairman; Director | 53,954,101 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $51.35 per share | 2,770,543,086.35 |
| Nov 5, 2026 | Mark Hancock Director | 53,330,643 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $50.38 per share | 2,686,797,794.34 |
| Nov 5, 2026 | Mark Hancock Director | 53,318,884 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $51.44 per share | 2,742,723,392.96 |
| Nov 5, 2026 | Michelle Lewis Chief Accounting Officer | 340,338 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $50.06 per share | 17,037,320.28 |